Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer

By Ferretti Gianluigi  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 319-319

Springer Publishing Company

Access to resources Recommend Favorite

Malignant Endometrial Polyps in Postmenopausal Breast Cancer Tamoxifen-Treated Patients

By Cohen I.   Bernheim J.   Azaria R.   Tepper R.   Sharony R.   Beyth Y.  

Gynecologic Oncology, Vol. 75, Iss. 1, 1999-10 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells

By Kurebayashi Junichi   Nukatsuka Mamoru   Nagase Hideki   Nomura Tsunehisa   Hirono Mai   Yamamoto Yutaka   Sugimoto Yoshikazu   Oka Toshinori   Sonoo Hiroshi  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 515-525

Springer Publishing Company

Access to resources Recommend Favorite

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer

By Masuda Norikazu   Iwata Hiraji   Rai Yoshiaki   Anan Keisei   Takeuchi Toru   Kohno Norio   Takei Hiroyuki   Yanagita Yasuhiro   Noguchi Shinzaburo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 443-451

Springer Publishing Company

Access to resources Recommend Favorite